Proactive engagement with industry and robust support for commercial opportunities is fostered through collaborative links with industry both at an overarching strategic level and through individual researchers.
A dedicated senior professional Business Engagement Partner, appointed in 2012, has facilitated the implementation of a focused strategy for promoting and developing academic-industry interactions, in particular longer-term strategic partnerships with major healthcare companies.
Business Engagement Operations Group
We have established an academic-led Business Engagement Operations Group with academic ‘champions’ from all Schools to identify new engagement opportunities and intellectual property (IP) potential. This approach has already borne strong results, with exemplars such as the Bioscience Ventures Ltd partnership with Abingdon Health. We also support specific Knowledge Transfer Secondments of academic staff into industry and NHS settings to increase knowledge and understanding of these translational environments.
College researchers have access to a dedicated Technology Transfer Team within the College’s Research & Knowledge Transfer Office working with individual academics to assess IP and commercialisation strategies.
The College External Commercialisation Board comprises top industry experts, including Simon Campbell (Senior VP, World-wide discovery, Pfizer), Malcolm Skingle (Director, European Academic Liaison, Global External Affairs, GlaxoSmithKline), Clive Dix (Chairman of Board, Bioindustry Association), Martin Murphy (CEO, Syncona Partners, the venture capital arm of Wellcome Trust) and Alan Boyd (R&D Director, Ark Therapeutics).
Their advice is linked to the University’s own dedicated commercialisation company, Alta Innovations that support the patent process and drive consulting, licensing and spin-out opportunities for our academics.